Merck & Co. Inc.

MRK NYS
Pharmaceuticals
Keniworth, NJ
2016 Revenue (US$ Millions)$39,807
Revenue Growth (%)0.78%
2015 Revenue (US$ Millions)$39,498
Net Income (US$ Millions)$3,920
Common Shares Outstanding (Millions)2,748.73
Earnings Per Share (US$)$1.41
Price to Earnings Ratio45.75
Total Equity (US$ Millions)$40,088
Return on Equity (%)8.77%
Long Term Debt (US$ Millions)$24,274
Debt to Equity Ratio (%)0.61%
Market Capitalization (US$ Millions)$161,818
Total Assets (US$ Millions)$95,377
Current Assets (US$ Millions)$30,614
Inventories (US$ Millions)$4,866
Current Liabilities (US$ Millions)$17,204
Cost Of Goods Sold (US$ Millions)$13,891
Asset Turnover0.4
Inventory Turnover2.9